Lixte Biotechnology
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.About LIXT
Lixte Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical company, which engages in the business of developing a drug class called protein phosphatase 2A inhibitors. The firm is also involved in utilizing biomarker technology to identify enzyme targets associated with serious common diseases and then designing novel compounds to attack those targets.
LIXT Key Statistics
Stock Snapshot
With a market cap of 25.08M, Lixte Biotechnology(LIXT) trades at $3.05. The stock has a price-to-earnings ratio of -2.59.
On 2026-02-16, Lixte Biotechnology(LIXT) stock moved within a range of $3.05 to $3.20. With shares now at $3.05, the stock is trading 0.0% above its intraday low and -4.7% below the session's peak.
Trading activity shows a volume of 24.68K, compared to an average daily volume of 75.46K.
The stock's 52-week range extends from a low of $0.64 to a high of $6.26.
The stock's 52-week range extends from a low of $0.64 to a high of $6.26.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.